Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06538571 · ClinicalTrials.gov registry record · NA
Association of Near Infrared Spectroscopy With Interstage Outcomes
A NA study of Single-ventricle, sponsored by Advocate Hospital System.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT06538571: Recruiting NA study of Single-ventricle, sponsored by Advocate Hospital System.
NCT06538571 is a NA study of Single-ventricle that is actively recruiting participants, run by Advocate Hospital System. The registered enrollment target is 20 participants, below the 85-participant average among 17 other Single-ventricle trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06538571, a NA study of Single-ventricle, is actively recruiting participants, sponsored by Advocate Hospital System.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to assess the utility of renal near infrared spectroscopy in the outpatient setting during the interstage period. The primary aim will be to determine the correlation between oxygen extraction ratio ((arterial pulse oximetry - renal near infrared spectroscopy value)/arterial pulse oximetry value) with need for inpatient admission or intervention. Secondary aims will be to determine the correlation of the oxygen extraction ratio with weight gain, neurodevelopment, unexpected admissions, systemic ventricular strain by echocardiography, and Glenn hospitalization admission characteristics.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Near infrared spectroscopy
Study Locations (1)
Illinois
- Advocate Childrens Hospital - Oak Lawn
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2024-07-01 |
| Est. Completion | 2026-07-01 |
| Phase | NA |
What NCT06538571 shows while recruiting
NCT06538571 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 85-participant average among 17 other Single-ventricle trials with a reported enrollment target (76% lower).
The record links to 1 condition, with Single-ventricle appearing as the primary indexed condition, and to 1 intervention - of which Near infrared spectroscopy is the first listed.
NCT06538571 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT06538571 about?
NCT06538571 is a clinical study titled "Association of Near Infrared Spectroscopy With Interstage Outcomes". The purpose of this study is to assess the utility of renal near infrared spectroscopy in the outpatient setting during the interstage period. The primary aim will be to determine the correlation between oxygen extraction ratio ((arterial pulse oximetry - renal near infrared spectroscopy value)/arte...
What is the current status of trial NCT06538571?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2024-07-01. Estimated completion is 2026-07-01.
What conditions does trial NCT06538571 study?
This clinical trial studies the following conditions: Single-ventricle.
What interventions are being tested in trial NCT06538571?
The interventions under investigation include: Near infrared spectroscopy (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06538571?
This trial is sponsored by Advocate Hospital System, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06538571 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Single-ventricle
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06538571's enrollment target sits among peer trials
20 13th of 17 higher than 3 of 17 other Single-ventricle trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Single-ventricle trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Fontan Fitness Trial
RECRUITING · NA
-
Re-Energize Fontan
RECRUITING · NA
-
Ventripoint Single Ventricle Study
RECRUITING · NA
-
REHAB Fontan Failure: A Trial of Cardiac Rehabilitation
RECRUITING · NA
-
Enhanced External Counterpulsation in Patients With Fontan Circulation
COMPLETED · NA
-
Improving Functional Capacity in Fontan Patients Through Inspiratory Muscle Training
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI